Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Urologix makes interim chief Greg Fluet permanent CEO

This article was originally published in Clinica

Executive Summary

Greg Fluet, who has been acting as Urologix's interim CEO since November, has been appointed to the role on a permanent basis. Mr Fluet, who has also been elected to the firm's board of directors, joined Urologix in July 2008 as chief operating officer and executive vice-president. He has been filling in as CEO since previous incumbent Stryker Warren retired last year (www.clinica.co.uk, 10 December 2012). Minneapolis, Minnesota-based Urologix, which is developing minimally-invasive devices to treat benign prostatic hyperplasia, is due to announce its second quarter results on 5 February.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099924

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel